MedTrace Logo

Patch Test Skin Irritation/Sensitization of Cetaphil Daily Advance Ultra Hydration Lotion

NCT01885130 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-07-29

No results posted yet for this study

Summary

Determine if Cetaphil Daily Advance Ultra Hydrating Lotion proves to be a contact sensitizer or irritant in certain individuals.

Conditions

  • Determine Sensitivity of Skin to Cetaphil Daily Advance Ultra Hydrating Lotion

Interventions

OTHER

Cetaphil Daily Advance Ultra Hydrating Lotion

0.2ml or 0.2g of Cetaphil on occlusive, hypoallergenic patch applied to skin for 24 hrs 9 times on Monday, Wednesday, and Friday for 3 weeks

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Principal Investigators

  • Mayya Tastene, MD · AMA Laboratories

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01885130 on ClinicalTrials.gov